These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 12939384)

  • 21. [Myocardial calcinosis as lethal complication in chronic kidney failure].
    Henning HV; Quellhorst E; Scheler F
    Med Klin; 1969 Sep; 64(36):1591-5. PubMed ID: 5344562
    [No Abstract]   [Full Text] [Related]  

  • 22. [Clinical evidence and treatment for optimum concentration of parathyroid hormone, calcium and phosphate in chronic renal failure].
    Hoshino J; Ubara Y; Takaichi K
    Clin Calcium; 2004 May; 14(5):731-7. PubMed ID: 15577034
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hyperparathyroidism in patients on chronic hemodialysis.
    Savoy GM; Yium JJ; Jordan PH; Guinn GA
    Am J Surg; 1973 Dec; 126(6):755-7. PubMed ID: 4758794
    [No Abstract]   [Full Text] [Related]  

  • 24. [Front line of management of hyperphosphatemia in hemodialysis patients].
    Yumita S
    Clin Calcium; 2004 May; 14(5):771-7. PubMed ID: 15577041
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Progress in the treatment of secondary hyperparathyroidism. Role of calcimimetics].
    Sułowicz W
    Przegl Lek; 2006; 63 Suppl 3():3-9. PubMed ID: 16898475
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cinacalcet hydrochloride in chronic kidney disease-mineral bone disorder.
    Yokoyama K
    Clin J Am Soc Nephrol; 2009 Sep; 4(9):1405-8. PubMed ID: 19696214
    [No Abstract]   [Full Text] [Related]  

  • 27. [Renal insufficiency is an important cardiovascular risk factor].
    Pérez Flores I; Luño J
    Nefrologia; 2002; 22(4):306-9. PubMed ID: 12369120
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical practice guideline for the management of secondary hyperparathyroidism in chronic dialysis patients.
    Guideline Working Group, Japanese Society for Dialysis Therapy
    Ther Apher Dial; 2008 Dec; 12(6):514-25. PubMed ID: 19140852
    [No Abstract]   [Full Text] [Related]  

  • 29. Consequences of hyperphosphatemia in patients with end-stage renal disease (ESRD).
    Qunibi WY
    Kidney Int Suppl; 2004 Sep; (90):S8-S12. PubMed ID: 15296501
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hyperparathyroidism in renal failure.
    Br Med J; 1978 Feb; 1(6110):390-1. PubMed ID: 624024
    [No Abstract]   [Full Text] [Related]  

  • 31. [Parathyroidectomy in secondary hyperparathyroidism in chronic uremic patients under dialysis treatment. Development of the surgical strategy].
    Zucchi C
    Minerva Med; 1985 Mar; 76(9-10):397-401. PubMed ID: 3982697
    [No Abstract]   [Full Text] [Related]  

  • 32. Cardiovascular mortality in chronic renal failure: hyperphosphatemia, coronary calcification, and the role of phosphate binders.
    Fatica RA; Dennis VW
    Cleve Clin J Med; 2002; 69 Suppl 3():S21-7. PubMed ID: 12086232
    [No Abstract]   [Full Text] [Related]  

  • 33. [Recent advances in the prevention of cardiovascular morbidity and mortality in end-stage renal disease: role of anemia, hyperparathyroidism and calcifications].
    Del Vecchio L; Pozzoni P; Limardo M; Caruso S; Fortunato M; Pontoriero G; Locatelli F
    G Ital Nefrol; 2007; 24 Suppl 38():25-32. PubMed ID: 17922444
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pathogenesis of hyperparathyroidism in renal failure].
    Galus K
    Pol Arch Med Wewn; 1974 Aug; 52(2):195-203. PubMed ID: 4605842
    [No Abstract]   [Full Text] [Related]  

  • 35. Hyperparathyroidism in the maintenance dialysis patient.
    Glassford DM; Remmers AR; Sarles HE; Lindley JD; Scurry MT; Fish JC
    Surg Gynecol Obstet; 1976 Mar; 142(3):328-32. PubMed ID: 1251311
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Metastatic calcinosis or calciphylaxis--a case with a severe vascular calcification during intermittent hemodialysis].
    Pogglitsch H; Feldner H; Stöckl G; Holzer H
    Wien Med Wochenschr; 1970 Jul; 120(30):532-4. PubMed ID: 5523384
    [No Abstract]   [Full Text] [Related]  

  • 37. Secondary hyperparathyroidism in chronic renal failure. The clinical spectrum in uremia, during hemodialysis, and after renal transplantation.
    Massry SG; Coburn JW; Popovtzer MM; Shinaberger JH; Maxwell MH; Kleeman CR
    Arch Intern Med; 1969 Oct; 124(4):431-41. PubMed ID: 4901739
    [No Abstract]   [Full Text] [Related]  

  • 38. [Hyperphosphatemia and cardiovascular risk in patients on dialysis].
    Basić-Jukić N; Kes P
    Acta Med Croatica; 2004; 58(3):207-13. PubMed ID: 15503684
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extraosseous calcification in patients with chronic renal failure--no escape?
    Braun J
    Nephrol Dial Transplant; 2005 Oct; 20(10):2054-9. PubMed ID: 16077145
    [No Abstract]   [Full Text] [Related]  

  • 40. [Outcome of osseous lesions of hyperparathyroidism in a patient with chronic renal failure treated with high doses of vitamin D].
    Verberckmoes R; Tanghe W; Michielsen P; Vandenbroucke J
    J Urol Nephrol (Paris); 1970 Sep; 76(9):790-7. PubMed ID: 5482082
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.